Target (CBDY) Invested Capital (2013 - 2026)
Target (CBDY) reported Invested Capital of -$8.5 million for Q1 2026, down 29.32% year-over-year from -$12.1 million in Q1 2025, and down 5.97% quarter-over-quarter from -$8.1 million in Q4 2025.
Target (CBDY) Invested Capital (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Invested Capital data on file, last reported at -$8.5 million in Q1 2026.
- Invested Capital for Q1 2026 came in at -$8.5 million, down 29.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.5 million (down 29.32% YoY), and the FY2025 annual result was -$8.1 million, down 23.93% from the prior year.
- Invested Capital eased to -$8.5 million in Q1 2026 per CBDY's latest filing, from -$8.1 million in the prior quarter.
- Over five years, Invested Capital peaked at -$2.8 million in Q3 2022 and troughed at -$8.5 million in Q1 2026.
- A 5-year average of -$6.8 million and a median of -$7.0 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Invested Capital tumbled 146.44% in 2023, then increased 6.68% in 2024.
- A 5-year view of Invested Capital shows it stood at -$6.5 million in 2022, then retreated by 6.42% to -$7.0 million in 2023, then grew by 6.68% to -$6.5 million in 2024, then declined by 23.93% to -$8.1 million in 2025, then declined by 5.97% to -$8.5 million in 2026.
- Business Quant data shows CBDY's Invested Capital at -$8.5 million in Q1 2026, -$8.1 million in Q4 2025, and -$7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 479.60 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.79 Bn |
| 10 | Target | - | - | 191,787.00 | -8.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.54 Mn |
| Dec 31, 2025 | -8.05 Mn |
| Sep 30, 2025 | -7.43 Mn |
| Jun 30, 2025 | -7.02 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Dec 31, 2024 | -6.50 Mn |
| Sep 30, 2024 | -6.99 Mn |
| Jun 30, 2024 | -6.38 Mn |
| Mar 31, 2024 | -7.06 Mn |
| Dec 31, 2023 | -6.96 Mn |
| Sep 30, 2023 | -6.83 Mn |
| Jun 30, 2023 | -6.55 Mn |
| Mar 31, 2023 | -7.30 Mn |
| Dec 31, 2022 | -6.54 Mn |
| Sep 30, 2022 | -2.77 Mn |
| Jun 30, 2021 | -4.23 Mn |
| Mar 31, 2021 | -5.24 Mn |
| Dec 31, 2020 | -3.51 Mn |
| Sep 30, 2020 | 1.74 Mn |
| Jun 30, 2020 | 5.22 Mn |